Samples | Conc. (μg/ml) | HeLa Cell Line | NIH/3T3 Cell Line | ||
---|---|---|---|---|---|
Inhibition (%) | IC50 (μg/ml) | Inhibition (%) | IC50 (μg/ml) | ||
Rh.Cr | 500 | 63.25 ± 0.20*** | 347.33 | 74.96 ± 0.21*** | 174.52 |
250 | 41.43 ± 1.15*** | 59.46 ± 0.54*** | |||
125 | 29.00 ± 1.50*** | 43.07 ± 1.02*** | |||
62.5 | 20.64 ± 1.60*** | 35.53 ± 0.61*** | |||
Rh.Hex | 500 | 36.33 ± 3.50*** | 572.61 | 53.86 ± 0.85*** | 439.26 |
250 | 15.46 ± 2.43*** | 40.60 ± 0.41*** | |||
125 | 07.33 ± 0.68*** | 28.33 ± 0.33*** | |||
62.5 | 05.03 ± 0.23*** | 21.50 ± 0.60*** | |||
Rh.Chf | 500 | 81.50 ± 0.86*** | 151.52 | 82.13 ± 0.88*** | 53.37 |
250 | 69.00 ± 2.80*** | 70.66 ± 0.49*** | |||
125 | 43.66 ± 0.89*** | 64.02 ± 1.11*** | |||
62.5 | 34.22 ± 0.23*** | 51.43 ± 0.61*** | |||
Rh.EtAc | 500 | 79.66 ± 0.89*** | 166.50 | 72.76 ± 0.78*** | 158.73 |
250 | 66.32 ± 1.30*** | 59.00 ± 0.57*** | |||
125 | 40.93 ± 0.49*** | 46.86 ± 0.85*** | |||
62.5 | 29.83 ± 1.36*** | 31.43 ± 0.81*** | |||
Rh.Aq | 500 | 60.83 ± 1.36*** | 369.68 | 65.60 ± 0.41*** | 237.62 |
250 | 42.53 ± 0.46*** | 51.96 ± 0.21*** | |||
125 | 33.61 ± 1.70*** | 42.66 ± 0.49*** | |||
62.5 | 21.33 ± 0.33*** | 36.13 ± 0.88*** | |||
Doxorubicin | 500 | 96.63 ± 1.67 | <0.1 | 98.53 ± 1.09 | <0.1 |
250 | 91.87 ± 0.25 | 93.76 ± 0.78 | |||
125 | 89.46 ± 2.43 | 90.33 ± 0.88 | |||
62.5 | 84.50 ± 0.86 | 87.46 ± 0.54 |